Education, Research & Positions
A ferritin-targeted biohybrid triggering ferroptosis immunotherapy via activating endogenous iron
A ferritin-targeted biohybrid triggering ferroptosis immunotherapy via activating endogenous iron and replenishing exogenous iron simultaneously Summary This research introduces a novel biohybrid nanoparticle that combats cancer by triggering ferroptosis and enhancing immunotherapy. The nanoparticles target Read More
